Feb 12, 2019Neurotech Pharmaceuticals, Inc. Granted Fast Track Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2.View PDF Version MacTel_FastTrack.pdfDownload PDF • 106KB
Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2.View PDF Version MacTel_FastTrack.pdfDownload PDF • 106KB